Tschernia, N., Orentas, R., & Mackall, C. (2014). Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors. J Immunother Cancer.
Citação norma ChicagoTschernia, Nicholas, Rimas Orentas, and Crystal Mackall. "Chondroitin Sulfate Proteoglycan 4 Specific Chimeric Antigen Receptor Therapy for Pediatric Solid Tumors." J Immunother Cancer 2014.
ציטוט MLATschernia, Nicholas, Rimas Orentas, and Crystal Mackall. "Chondroitin Sulfate Proteoglycan 4 Specific Chimeric Antigen Receptor Therapy for Pediatric Solid Tumors." J Immunother Cancer 2014.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.